While most patients with FXS have a complete methylation of the FMR1 gene, some have methylation mosaicism (a proportion of cells that are methylated and other cells are unmethylated) or size mosaicism (some cells with the premutation and other cells with FM). This evidence concerns the gene FMR1 and fragile X syndrome.